Highlights in valvular heart disease research - The year in EuroIntervention

In collaboration with EuroIntervention

Anchorperson: M. Joner

Spokesperson: J. Wykrzykowska

Summary

This session highlights the most impactful research in valvular heart disease published in EuroIntervention in 2025. It reviews pivotal studies such as the ASCoP registry on complex PCI in severe aortic stenosis, the LANDMARK trial comparing Myval THV to other valves, and the D-PACE scoring system for predicting conduction disturbances post-TAVI. Direct interaction with leading investigators offers in-depth understanding of these advances and their clinical implications.

Learning Objectives

To know more about the EuroIntervention publications with most impact in 2025
To appreciate the implications of these studies for everyday clinical practice
To interact directly with leading investigators in the field of valvular heart disease

Presentations available when logged in:

Welcome and session objectives
Complex PCI in patients with severe aortic stenosis: the ASCoP registry
TAVI outcomes with the Myval THV series compared to contemporary balloon-expandable and self-expanding valves - the LANDMARK trial
Prediction of high-grade conduction disturbances after TAVI - the D-PACE scoring system
Session evaluation and key learnings

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Highlights in valvular heart disease research - The year in EuroIntervention

In collaboration with EuroIntervention

Learning Objectives

Log in or create account for free